483
Boston Medical Products, Inc.Boston Medical Products, Inc. – FDA 483, Jul 12, 2023
Record Details
An FDA inspection of Boston Medical Products, Inc., a distributor in Shrewsbury, MA, revealed a significant procedural deficiency. The firm failed to develop written procedures for the surveillance, receipt, evaluation, and reporting of post-marketing adverse drug experiences for its approved drug product, Steritalc. This indicates a lack of essential controls for drug safety reporting.
- Person
View Company Profile
ID · 3eb883c3-4e57-4c56-a540-2802f6a2000a
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.